663 research outputs found
Towards Post Development in India. Lessons of Community Resilience in Times of Crises
No full textAuthor: Ashish Kothari is an Indian environmentalist working on development – environment interface, biodiversity policy, and alternatives. Environment and wildlife have been his passions since high school in Delhi, when (in 1978-79) he helped found Kalpavriksh, a non-profit organisation in India which deals with environmental and development issues. Since then, he has been associated with peoples’ movements like Narmada Bachao Andolan and Beej Bachao Andolan. He is also involved in coordinateing national and global networks like Vikalp Sangam and Global Tapestry of Alternatives
Radical Ecological Democracy: Escaping India's globalization trap
No full textThe global economic and ecological crises can be seen as an opportunity to fundamentally question our paths of ‘development’, and move towards ideologies, policies, and practices of ecological sustainability and social equity. India in its current globalizing form, presents a vivid picture of unsustainability. But, Ashish Kothari proposes that in its ancient and new ideologies and its myriad grassroots experiments in alternatives, it could also be the harbinger of revolutionary changes in the way humans relate to the earth and to each other.
Ashish Kothari, Ariel Salleh, Arturo Escobar, Federico Demaria, Alberto Acosta, eds, Pluriverso: Dizionario del Post-Sviluppo, edizione italiana a cura di Maura Benegiamo, Alice Dal Gobbo, Emanuele Leonardi, Salvo Torre, Pisa, Orthotes, 2021, pp. 491
No full textBook review of Ashish Kothari, Ariel Salleh, Arturo Escobar, Federico Demaria, Alberto Acosta, eds, Pluriverso: Dizionario del Post-Sviluppo, Italian edition edited by Maura Benegiamo, Alice Dal Gobbo, Emanuele Leonardi, Salvo Torre, Pisa, Orthotes, 2021, pp. 491.Recensione di Ashish Kothari, Ariel Salleh, Arturo Escobar, Federico Demaria, Alberto Acosta, eds, Pluriverso: Dizionario del Post-Sviluppo, edizione italiana a cura di Maura Benegiamo, Alice Dal Gobbo, Emanuele Leonardi, Salvo Torre, Pisa, Orthotes, 2021, pp. 491
Shrivastava, Aseem/Kothari, Ashish: Churning the Earth. The Making of Global India, Penguin/Viking, New Delhi/New York/Toronto/London 2012 [...] [Sammelrezension]
No full textSammelrezension von: 1. Shrivastava, Aseem/Kothari, Ashish: Churning the Earth. The Making of Global India, Penguin/Viking, New Delhi/New York/Toronto/London 2012. 2. Dietz, Rob/O’Neill, Dan: Enough is Enough. Building a Sustainable Economy in a World of Finite Resources, Earthscan, Oxford 2013. 3. Zovanyi, Gabor: The No-Growth Imperative. Creating Sustainable Communities under Ecological Limits to Growth, Earthscan, Oxford 201
The Zapatistas’ dialogue with European movements
No full textModerators: Gustavo ESTEVA (Earth University, Mexico) LAU Kin Chi (Lingnan University, Hong Kong, China)
Speakers: Alejandra JIMÉNEZ RAMÍREZ (National Indigenous Congress, Mexico) Elena FUSAR-POLI (Cantiere, Italy)
Discussant: Ashish KOTHARI (Global Tapestry of Alternatives, India
Ecological justice through social transformation (II) = 生態正義必由之路 : 社會變革 (II)
No full textSIT Tsui Jade Margaret (Southwest University, China) moderated the session of Ecological Justice through Social Transformation (II).
Speakers: Rebecca JOHNSON (ICAN, 2017 Nobel Peace Prize Laureate, UK) Jayati GHOSH (Jawaharlal Nehru University, India) Mithika MWENDA (University of Witwatersrand, South Africa)
Discussants: Gustave MASSIAH (Attac France) Ashish KOTHARI (Global Tapestry of Alternatives, India) ZHOU Li (Renmin University of China, China) Rita PADAWANGI (Singapore University of Social Science, Singapore) CHOW Sze Chung (Sangwoodgoon, Hong Kong, China
Alternative futures: India unshackled
No full textTítulo: Alternative futures: India unshackled
Editores: Ashish Kothari y K. J. Joy
Año: 2017
Editorial: AuthorsUpFront Publishing Services Private Limited, Nueva Delhi
Idioma: Inglés
Páginas: 68
Book review: Valuable up-to-date information-rich resource
No full textManaging Protected Areas: a Global Guide edited by Michael Lockwood, Graeme L Worboys and Ashish Kothari Earthscan, London, 2006, 802 pages, £49.95 (~US$100), ISBN 1-84407-303-
RTA 2012 Proceedings Frontmatter
No full textFrontmatter, Table of Contents, Conference Organization, External Reviewers, Author Index
Impact of the Conformité Européene mark approval on exit opportunities and validation for early stage medical device companies
No full textThesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2011.Cataloged from PDF version of thesis.Includes bibliographical references (p. 85-87).The aim of this thesis was to look at the impact of acquiring the CE marking approval on the outcome of early stage medical device companies, specifically its impact on strategic acquisition opportunities and on valuation. We gathered data on acquisitions of 237 companies over the past ten years, from April 01, 2002 to March 31, 2011. These data were gathered from various sources, and information on the date of acquisition, enterprise value, funds invested to date, date of incorporation, status and dates of CE and FDA approvals, patent status, type of regulatory clearances (PMA versus 510K), type of sales models (direct versus distributorship), capitalization status and last twelve month stock returns of the acquirer was acquired. These data were then analyzed using basic statistical methods and multivariate linear regression analyses to determine the significance of the CE marking on the outcomes of these companies. Our results support the claim that the CE mark does significantly improve outcomes for early stage medical device companies, in terms of time to strategic acquisition, which is by far the commonest exit route for these companies. On the other hand, we did not find any statistically significant impact of acquisition of the CE mark on the valuation or valuation multiples of these companies. These results have potential implications for management of these early stage medical device companies in making strategic decisions and for investors who are concerned about the exit opportunities and valuations, especially as it relates to funds invested. There could also be some policy implications in terms of the effort, duration and cost of getting a CE approval versus that of an FDA approval, which is especially important given the current growing concern about increasingly stringent regulation, rising costs and increasing delays in FDA approvals for medical devices.by Ashish Kothari.S.M
- …
